Matches in Nanopublications for { ?s ?p "[The PTEN/AKT/mTOR signaling pathway and the Evi1-polycomb interaction can be promising therapeutic targets for leukemia with activated Evi1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- assertion description "[The PTEN/AKT/mTOR signaling pathway and the Evi1-polycomb interaction can be promising therapeutic targets for leukemia with activated Evi1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The PTEN/AKT/mTOR signaling pathway and the Evi1-polycomb interaction can be promising therapeutic targets for leukemia with activated Evi1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The PTEN/AKT/mTOR signaling pathway and the Evi1-polycomb interaction can be promising therapeutic targets for leukemia with activated Evi1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP232051.RARQTl7qGEvnq2VD06Xmdffo3MfzRgqG-F6ZtV9htK0NY130_assertion description "[The PTEN/AKT/mTOR signaling pathway and the Evi1-polycomb interaction can be promising therapeutic targets for leukemia with activated Evi1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP232051.RARQTl7qGEvnq2VD06Xmdffo3MfzRgqG-F6ZtV9htK0NY130_provenance.
- NP317596.RABBpD1Fgeq9sBBriaSHI7aA0gc4eiJ55z2EEYOVjFNSk130_assertion description "[The PTEN/AKT/mTOR signaling pathway and the Evi1-polycomb interaction can be promising therapeutic targets for leukemia with activated Evi1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP317596.RABBpD1Fgeq9sBBriaSHI7aA0gc4eiJ55z2EEYOVjFNSk130_provenance.
- NP869867.RAk5UCPs5F12rUaXIOp4dS0IzXesasB0eRNj0NUJFAM00130_assertion description "[The PTEN/AKT/mTOR signaling pathway and the Evi1-polycomb interaction can be promising therapeutic targets for leukemia with activated Evi1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869867.RAk5UCPs5F12rUaXIOp4dS0IzXesasB0eRNj0NUJFAM00130_provenance.
- NP869869.RAuCHyqMHBRYPv483EFTKukNThcmiThsFVjaKDty3Jkr4130_assertion description "[The PTEN/AKT/mTOR signaling pathway and the Evi1-polycomb interaction can be promising therapeutic targets for leukemia with activated Evi1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869869.RAuCHyqMHBRYPv483EFTKukNThcmiThsFVjaKDty3Jkr4130_provenance.
- NP869864.RAPc7cX4NxvqQI6Xk-yg-k1Zmw2SEzDBYLsoa1UCa7BDw130_assertion description "[The PTEN/AKT/mTOR signaling pathway and the Evi1-polycomb interaction can be promising therapeutic targets for leukemia with activated Evi1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869864.RAPc7cX4NxvqQI6Xk-yg-k1Zmw2SEzDBYLsoa1UCa7BDw130_provenance.